Development, validation and comparison of UHPSFC and UHPLC methods for the determination of agomelatine and its impurities.

Agomelatine is one of the newest antidepressants. Due to a different mechanism of action it offers a completely new approach in the treatment of depressive disorders. Two chromatographic methods for determination of agomelatine and its impurities were developed. The separations on UHPSFC system were accomplished using stationary phase based on BEH 2-EP and gradient elution with CO2 and methanol containing 20mM ammonium formate and 5% of water. The UHPLC separations were performed on stationary phase BEH Shield RP18. The mixture of acetonitrile and methanol in ratio 1:1 and ammonium acetate buffer pH 9.5 were used as mobile phase. Both developed methods were properly validated in terms of linearity, sensitivity (LOD, LOQ), accuracy and precision according to ICH guidelines. The UHPSFC method was linear in the range 0.25-70μg/ml for all analytes with method accuracy ≥97.4% and ≥100.2% and method intra-day precision RSD ≤2.4 and ≤0.8 for impurities and API (active pharmaceutical ingredient), respectively. The UHPLC method was linear in the range 0.1-10μg/ml for all analytes except three impurities for which the linear range was larger 0.1-25μg/ml. Method accuracy ≥95.7% and ≥95.2% and method intra-day precision RSD ≤2.6 and ≤1.5 were found for impurities and API, respectively. The measurement of tablet samples was performed and the selected parameters of the methods were compared. In conclusion, both methods were appropriate for the determination of agomelatine and its impurities in pharmaceutical quality control (QC), although the UHPSFC method was found as more convenient especially in the method development phase. The advantages of newly developed UHPSFC-PDA (photo diode array detector) method were its environmental friendliness due to the mobile phase used, a very good resolution, selectivity and high speed of analysis (total time of separation was 4.1min).

[1]  Davy Guillarme,et al.  Supercritical fluid chromatography in pharmaceutical analysis. , 2015, Journal of pharmaceutical and biomedical analysis.

[2]  E. Lesellier,et al.  Overview of the retention in subcritical fluid chromatography with varied polarity stationary phases. , 2008, Journal of separation science.

[3]  H. Möller,et al.  Agomelatine: The evidence for its place in the treatment of depression , 2009, Core evidence.

[4]  J. P. Jeanniot,et al.  Determination of melatonin in biological fluids in the presence of the melatonin agonist S 20098: comparison of immunological techniques and GC-MS methods. , 1999, Journal of pharmaceutical and biomedical analysis.

[5]  Caroline West,et al.  A unified classification of stationary phases for packed column supercritical fluid chromatography. , 2008, Journal of chromatography. A.

[6]  E. Lesellier,et al.  Characterization of five chemistries and three particle sizes of stationary phases used in supercritical fluid chromatography. , 2013, Journal of chromatography. A.

[7]  Serge Rudaz,et al.  Evaluation and comparison of various separation techniques for the analysis of closely-related compounds of pharmaceutical interest. , 2013, Journal of chromatography. A.

[8]  E. Lesellier Retention mechanisms in super/subcritical fluid chromatography on packed columns. , 2009, Journal of chromatography. A.

[9]  R. Sansone,et al.  Agomelatine: a novel antidepressant. , 2011, Innovations in clinical neuroscience.

[10]  Caroline West,et al.  The many faces of packed column supercritical fluid chromatography--a critical review. , 2015, Journal of chromatography. A.

[11]  Davy Guillarme,et al.  Modern analytical supercritical fluid chromatography using columns packed with sub-2 μm particles: a tutorial. , 2014, Analytica chimica acta.

[12]  M. Amore,et al.  Multi-matrix assay of the first melatonergic antidepressant agomelatine by combined liquid chromatography-fluorimetric detection and microextraction by packed sorbent. , 2014, Journal of pharmaceutical and biomedical analysis.

[13]  S. Kennedy,et al.  Agomelatine and its therapeutic potential in the depressed patient , 2007, Neuropsychiatric disease and treatment.

[14]  David Taylor,et al.  Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies , 2014, BMJ : British Medical Journal.

[15]  E. Lesellier,et al.  Development of an achiral supercritical fluid chromatography method with ultraviolet absorbance and mass spectrometric detection for impurity profiling of drug candidates. Part II. Selection of an orthogonal set of stationary phases. , 2015, Journal of chromatography. A.

[16]  E. Lesellier,et al.  Development of an achiral supercritical fluid chromatography method with ultraviolet absorbance and mass spectrometric detection for impurity profiling of drug candidates. Part I: Optimization of mobile phase composition. , 2015, Journal of chromatography. A.

[17]  Davy Guillarme,et al.  Comparison of ultra-high performance supercritical fluid chromatography and ultra-high performance liquid chromatography for the analysis of pharmaceutical compounds. , 2012, Journal of chromatography. A.

[18]  G. Martinotti,et al.  The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice , 2013, International journal of molecular sciences.